Showing results (1701-1710 of 1,909) with videos related to
Sort By:
Pageof 191
American Heart Journal|April 29, 2006
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) programAnique Ducharme, Karl Swedberg, Marc A Pfeffer, et al.Journal of the American College of Emergency Physicians Open|May 22, 2024
"Right now, it's kind of haphazard"-Pediatric emergency care coordinators and quality of emergency care for children: A qualitative studyMargaret Samuels-Kalow, Krislyn M Boggs, Stephanie S Loo, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 19, 2023
Developing machine learning models to predict primary graft dysfunction after lung transplantationAndrew P Michelson, Inez Oh, Aditi Gupta, et al.Journal of Clinical Pharmacology|September 15, 2021
Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE StudyPeijuan Zhu, Stefan Willmann, Wangda Zhou, et al.Leukemia|July 16, 2011
A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemiaJ E Lancet, F Ravandi, R M Ricklis, et al.Journal of Telemedicine and Telecare|September 10, 2002
Telemedicine in the service of peaceDan Shanit, Werner Striebel, Georg Michelson, et al.The American Journal of Psychiatry|November 2, 2002
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled studyDavid Michelson, Albert J Allen, Joan Busner, et al.Circulation|June 15, 2007
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programEileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.Headache|October 20, 2012
Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineursDavid J Hewitt, Eric Pearlman, Mirja Hämäläinen, et al.Journal of the American College of Cardiology|May 7, 2011
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudyBenjamin M Scirica, Christopher P Cannon, Håkan Emanuelsson, et al.Pageof 191